The sales launch of legal marijuana in California has sent related stocks flying, but investors should be careful. Rather than bet on one or two companies, it may be better to do this. Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Analyst Articles
These two companies enjoy leadership and strong execution in industries with sustainable demand growth. Their stocks have stalled a little lately but both should regain momentum in 2018. Read More
Investors should not neglect emerging markets. This ETF offers diversified exposure to emerging markets, with a focus on the fast-growing region of Asia. Read More
Sell ViaSat (Nasdaq: VSAT). The stock has been rallying strongly. It looks like part of the rally is driven by short covering. We recommend taking the gain for now. We will continue to monitor the stock and there’s a good chance we will return to the position. Read More
Snap Inc. has disclosed that Chinese tech behemoth owns a 12 percent stake. The company looks like it needs outside help. On its own the company is struggling and losing to Facebook's Instagram. Read More
The 529 Plan and the Coverdell ESA are two tax-advantaged education saving plans available for Americans. There are some key differences between the two plans. Understanding their pros and cons can help you determine which plan better fits your needs. Read More
Core Growth Portfolio biotech holding Biogen Idec (Nasdaq: BIIB) has gained about 35 percent since the end of May as fears of a generic threat and revenue slowdown subsided. It set a new 52-week high last Friday after weekly sales of Tecfidera (the face of Biogen’s MS franchise) grew 3.1… Read More
When planning for retirement, investors shouldn’t ignore annuities. The key is finding the annuities that are right for you, from low-cost and credible providers. Read More
Merger talk between T-Mobile (Nasdaq: TMUS) and Sprint (NYSE: S) is again heating up. While a marriage between the third and fourth largest U.S. national mobile carriers may not be a great thing for consumers, from an investment perspective it looks like it could be a "win-win" situation for both companies. Read More
Exchange-traded funds, better known by their acronym ETFs, are investment funds that have become increasingly popular in recent years. This week we take a look at four main ways they are structured and some differences among them. Read More